|
2022
|
Invention
|
Bacterial hosts for recombinant protein expression. The present invention provides recombinant gr... |
|
|
Invention
|
Anthrax vaccine. B. anthracisB. anthracisB. anthracisB. anthracis, the method comprising administ... |
|
2021
|
Invention
|
Methods of purifying charge-shielded fusion proteins.
The present invention relates to method of... |
|
|
Invention
|
Methods of purifying charge-shielded fusion proteins. The present invention relates to method of ... |
|
2020
|
Invention
|
Erwinia asparaginase. Erwinia asparaginase. Methods herein produce asparaginase having high expre... |
|
|
G/S
|
pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell produc... |
|
|
G/S
|
Pharmaceutical preparations, namely, pharmaceuticals used for stimulating white blood cell produc... |
|
2018
|
Invention
|
Bacterial leader sequences for periplasmic protein expression. Provided herein are bacterial lead... |
|
|
Invention
|
Method for production of recombinant erwinia asparaginase. Provided herein are methods of product... |
|
|
Invention
|
E. coli asparaginase. E. coliPseudomonadales Pseudomonadales host cells at high expression levels... |
|
|
Invention
|
Expression of mammalian proteins in pseudomonas fluorescens.
The invention is a process for impr... |
|
2017
|
G/S
|
Pharmaceutical preparations, namely, pharmaceuticals used for the prevention and treatment of bon... |
|
|
G/S
|
Pharmaceutical preparations, namely, anthrax vaccine; pharmaceutical and veterinary preparations ... |
|
|
G/S
|
pharmaceutical preparations, namely, pharmaceuticals used for the prevention and treatment of bon... |
|
2015
|
Invention
|
Fusion partners for peptide production. The present invention relates to the field of medicine, i... |
|
|
Invention
|
Method for producing soluble recombinant interferon protein without denaturing. The present inven... |
|
2014
|
Invention
|
High level expression of recombinant toxin proteins.
The present invention relates to the field ... |
|
2013
|
Invention
|
Process for purifying recombinant plasmodium falciparum circumsporozoite protein. The present inv... |
|
2011
|
Invention
|
Methods for g-csf production in a pseudomonas host cell. The present invention relates to the fie... |
|
|
Invention
|
High level expression of recombinant toxin proteins. The present invention relates to the field o... |
|
2010
|
Invention
|
Bacterial leader sequences for increased expression.
Compositions and methods for improving expr... |
|
|
Invention
|
Production of recombinant proteins utilizing non-antibiotic selection methods and the incorporati... |
|
|
Invention
|
High level expression of recombinant crm197. The present invention relates to the field of recomb... |
|
2009
|
Invention
|
High throughput screening method and use thereof to identify a production platform for a multifun... |
|
|
Invention
|
Design for rapidly cloning one or more polypeptide chains into an expression system.
The present... |
|
2008
|
Invention
|
High copy number self-replicating plasmids in pseudomonas. Pseudomonas-specific replication contr... |
|
|
Invention
|
Translation initiation region sequences for optimal expression of heterologous proteins.
The pre... |
|
|
Invention
|
Translation initiation region sequences for the optimal expression of heterologous proteins. The ... |
|
|
Invention
|
Expression of soluble antibody fragment by truncation of ch1 domain.
Improved expression of acti... |
|
|
Invention
|
Production and in vivo assembly of soluble recombinant icosahedral virus-like particles.
The pre... |
|
2007
|
Invention
|
Modified plant viruses and methods of use thereof. The present invention relates to modulating th... |
|
|
Invention
|
Codon optimization method. A heterologous expression in a host Pseudomonas bacteria of an optimiz... |
|
|
Invention
|
Processes for improved disulfide bond formation in recombinant systems.
Methods and prokaryotic ... |
|
2006
|
Invention
|
Novel plant virus particles and methods of inactivation thereof.
The present invention relates g... |
|
|
Invention
|
Novel plant virus particles and methods of inactivation thereof.
The present invention... |
|
|
Invention
|
Recombinant flu vaccines.
The present invention provides compositions for use as vaccines agains... |
|
|
Invention
|
Recombinant flu vaccines.
The present invention provides compositions for use as vacci... |
|
|
Invention
|
Production of multivalent virus like particles.
The present invention is directed to the product... |
|
|
Invention
|
Production of multivalent virus like particles.
The present invention is directed to t... |
|
2005
|
Invention
|
High efficiency peptide production in plant cells.
The present invention provides an i... |
|
|
Invention
|
Benzoate-and anthranilate-inducible promoters. Novel benzoate- or anthranilate-inducible promoter... |
|
2004
|
Invention
|
Recombinant icosahedral virus like particle production in pseudomonads.
The present invention pr... |
|
|
Invention
|
Recombinant icosahedral virus like particle production in pseudomonads.
The present in... |
|
|
Invention
|
Protein expression systems.
The present invention provides an improved expression system for the... |
|
2002
|
Invention
|
Viral particles with exogenous internal epitopes. The present invention relates to the expression... |
|
|
Invention
|
Chimaeric plant viruses with mucin peptides. Mucin peptide epitopes are inserted into the coat pr... |
|
2000
|
Invention
|
Modified plant viruses as vectors. The invention relates to assembled particles of a plant virus ... |
|
1999
|
Invention
|
Modified plant viruses as vectors of heterologous peptides. The invention relates to assembled pa... |
